Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
September 30, 2023 4.57%
June 30, 2023 51.89%
March 31, 2023 52.86%
September 30, 2022 14.26%
June 30, 2022 16.71%
March 31, 2022 13.71%
December 31, 2021 0.54%
September 30, 2021 14.73%
June 30, 2021 21.22%
March 31, 2021 27.32%
September 30, 2020 -0.05%
June 30, 2020 19.24%
March 31, 2020 19.85%
September 30, 2019 -34.84%
June 30, 2019 4.35%
March 31, 2019
December 31, 2018 -0.21%
September 30, 2018 13.24%
June 30, 2018 51.71%
March 31, 2018 -147.9%
December 31, 2017 9.78%
September 30, 2017 3.67%
June 30, 2017 17.52%
March 31, 2017 12.14%
December 31, 2016 0.08%
Date Value
September 30, 2016 -10.19%
June 30, 2016 8.44%
March 31, 2016 -9.50%
December 31, 2015 10.68%
September 30, 2015 14.23%
June 30, 2015 26.46%
March 31, 2015 24.26%
December 31, 2014 0.73%
September 30, 2014 30.10%
June 30, 2014 6.58%
March 31, 2014 23.20%
December 31, 2013 17.81%
September 30, 2013 31.60%
June 30, 2013 29.21%
March 31, 2013 31.65%
December 31, 2012 20.34%
September 30, 2012 17.18%
June 30, 2012 15.44%
March 31, 2012 35.09%
December 31, 2011 36.26%
September 30, 2011 19.19%
June 30, 2011 22.97%
March 31, 2011 25.65%
December 31, 2010 17.69%
September 30, 2010 35.42%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Cencora, Inc. 3.93%
Cardinal Health, Inc. 3.87%
McKesson Corp. 3.31%
Amexdrug Corp. 55.53%
Henry Schein, Inc. 29.81%